Vascular and renal calcification as a consequence of high-dose calcium and vitamin D drugs

Vrach Pub Date : 2024-02-02 DOI:10.29296/25877305-2024-02-15
V. Strukov, M. Sergeeva-Kondrachenko, A. Denisova, I. Moiseeva, O. Vinogradova, E. Panina, E. Petrova, N. Galkina, A. Pronkina, O. Gorina, D. Elistratov, S. Burmistrova, D. Agafonov
{"title":"Vascular and renal calcification as a consequence of high-dose calcium and vitamin D drugs","authors":"V. Strukov, M. Sergeeva-Kondrachenko, A. Denisova, I. Moiseeva, O. Vinogradova, E. Panina, E. Petrova, N. Galkina, A. Pronkina, O. Gorina, D. Elistratov, S. Burmistrova, D. Agafonov","doi":"10.29296/25877305-2024-02-15","DOIUrl":null,"url":null,"abstract":"Calcium-containing drugs occupy an important place in the list of anti-osteoporotic agents. Their consumption, often in combination with high doses of vitamin D, has increased significantly over the last couple of decades. Cases of uncontrolled intake of the macronutrient have become more frequent. Aggressive advertising of high-dose calcium supplements with calciferol of foreign production on television played its role in this. Nowadays doctors of various specialties have to face more and more often the consequences of using such preparations. The article describes the mechanism of calcium deposits formation in vessels and kidneys against the background of calcium supplementation. The results of large-scale studies proving the close relationship between high intake of calcium and vitamin D with calcification of vessels, development of cardiovascular diseases and nephrolithiasis are presented. Doubts are raised about the validity and necessity of high-dose calcium supplements in the treatment of skeletal diseases. The possibilities of successful therapy of postmenopausal osteoporosis without the use of such agents are presented on the example of the preparation Osteo-Vit D3, which does not contain calcium and high doses of calciferol, but increases the mineral density of bone tissue and reduces the volume of calcificates in blood vessels and kidneys.","PeriodicalId":23748,"journal":{"name":"Vrach","volume":"241 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vrach","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29296/25877305-2024-02-15","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Calcium-containing drugs occupy an important place in the list of anti-osteoporotic agents. Their consumption, often in combination with high doses of vitamin D, has increased significantly over the last couple of decades. Cases of uncontrolled intake of the macronutrient have become more frequent. Aggressive advertising of high-dose calcium supplements with calciferol of foreign production on television played its role in this. Nowadays doctors of various specialties have to face more and more often the consequences of using such preparations. The article describes the mechanism of calcium deposits formation in vessels and kidneys against the background of calcium supplementation. The results of large-scale studies proving the close relationship between high intake of calcium and vitamin D with calcification of vessels, development of cardiovascular diseases and nephrolithiasis are presented. Doubts are raised about the validity and necessity of high-dose calcium supplements in the treatment of skeletal diseases. The possibilities of successful therapy of postmenopausal osteoporosis without the use of such agents are presented on the example of the preparation Osteo-Vit D3, which does not contain calcium and high doses of calciferol, but increases the mineral density of bone tissue and reduces the volume of calcificates in blood vessels and kidneys.
大剂量钙和维生素 D 药物导致血管和肾脏钙化
含钙药物在抗骨质疏松药物中占有重要地位。在过去几十年中,含钙药物的服用量大幅增加,通常与大剂量维生素 D 同时服用。无节制地摄入大量营养素的病例也越来越多。电视上大肆宣传国外生产的含有钙化醇的高剂量钙补充剂也是原因之一。如今,各科医生不得不越来越频繁地面对使用此类制剂的后果。文章介绍了在补钙背景下血管和肾脏中钙沉积形成的机制。大规模研究的结果证明,大量摄入钙和维生素 D 与血管钙化、心血管疾病和肾结石的发生密切相关。对高剂量钙补充剂治疗骨骼疾病的有效性和必要性提出了质疑。以不含钙和高剂量钙化醇的制剂 Osteo-Vit D3 为例,介绍了不使用此类制剂成功治疗绝经后骨质疏松症的可能性,该制剂可增加骨组织的矿物质密度,减少血管和肾脏的钙化体积。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信